Browsing: Mdunik

Conditions

Médunik Canada becomes exclusive distributor of INCRELEX® in Canada, strengthening support for children with a rare growth disorder

By 0

BLAINVILLE, QC, July 14, 2026 /CNW/ – Médunik Canada, a Canadian owned and operated pharmaceutical company dedicated to improving the health and quality of life of people living with rare and debilitating diseases, part of Duchesnay Pharmaceutical Group, is pleased to announce that it has become the exclusive distributor of INCRELEX® (mecasermin), a recombinant human…